北美人工皮肤市场规模和股份 2025-2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. North America Artificial Skin Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Technological advancements enhance effectiveness of artificial skin solutions.

3.2.2. Greater awareness promotes adoption of artificial skin treatments.

3.2.3. Aging population raises susceptibility to skin-related medical conditions.

3.3. Key industry pitfalls & challenges

3.3.1. High treatment costs limit accessibility for many patients.

3.3.2. Stringent regulations delay product approvals and market access.

3.3.3. Limited awareness among professionals impedes market growth potential.

3.4. Market Opportunities

3.4.1. Strategic partnerships enhance product development and distribution capabilities.

3.4.2. Interest in regenerative medicine creates opportunities for innovation.

3.4.3. Demand for personalized solutions drives tailored artificial skin development.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. North America Artificial Skin Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Collagen-based

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Silicone-based

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Polyurethane

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Others

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. North America Artificial Skin Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Burn Treatment

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Wound Healing

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Cosmetic Applications

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Reconstructive Surgery

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. North America Artificial Skin Market, Material Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Material, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Natural Artificial Skin

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Synthetic Artificial Skin

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Both

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. North America Artificial Skin Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Burn Care Centers

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Hospitals

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Plastic Surgery Centers

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. North America Artificial Skin Market, Region Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Region, 2025 & 2035

8.1.2. Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Material, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Material, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Material, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Organogenesis Inc.

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Acelity L.P. Inc.

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. MediWound Ltd.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Integra LifeSciences Corporation

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Collagen Matrix, Inc.

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Regenicin, Inc.

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Sientra, Inc.

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Avita Medical

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Vericel Corporation

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Epic Sciences, Inc.

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Kerecis

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Cytori Therapeutics

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Acelity

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Athersys, Inc.

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Tissue Regenix

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis